Insider Transactions Reported by 18 Insiders of Barinthus Biotherapeutics plc.

Symbol
BRNS on Nasdaq
Location
Germantown, MD

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Barinthus Biotherapeutics plc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Geoffrey Lynn Chief Scientific Officer $1,560,994 17 Dec 2024
Leon Hooftman Chief Medical Officer 03 Feb 2025
Karen A. Dawes Director 10 Jun 2025
Graham Griffiths Chief Business Officer 03 Feb 2025
Gemma Brown Chief Financial Officer 03 Feb 2025
Joseph Scheeren Director 10 Jun 2025
Nadege Pelletier Chief Scientific Officer 02 Jan 2024
Alex Hammacher Director 10 Jun 2025
Robin Wright Director 10 Jun 2025
William Enright Chief Executive Officer, Director 03 Feb 2025
Anne M. Phillips Director 10 Jun 2025
Pierre A. Morgon Director 10 Jun 2025
M&G Alternatives Investment Management Ltd 10%+ Owner 30 Sep 2022
Thomas George Evans Fmr Chief Scientific Officer 03 Jan 2023
Georgy Egorov Chief Financial Officer 03 Jan 2022
Christopher Ellis Chief Operating Officer 03 Jan 2023
Margaret Marshall Chief Medical Officer 03 Jan 2023
M&G INVESTMENT MANAGEMENT LTD 10%+ Owner 30 Sep 2022

Recent Insider Transactions by Companies or Individuals for Barinthus Biotherapeutics plc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Alex Hammacher BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Robin Wright BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Pierre A. Morgon BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Anne M. Phillips BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Joseph Scheeren BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
Karen A. Dawes BRNS Share Option (Right to Buy) Award 20,174 20,174 10 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.